PARATEK PHARMACEUTICALS, INC.
PRTKUnited States
33 filed reports · 402 financial concepts
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
Latest fiscal year
Filed reports
33 reports · Jun 2015 to Jun 2023Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 25 | 3,212 | Jun 2015 to Jun 2023 |
| Annual · 10-KSEC EDGAR | 8 | 2,861 | Dec 2015 to Dec 2022 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2023 Q2 | 10-Q | 2023-06-30 | 2023-08-03 | 295 | Open |
| FY2023 Q1 | 10-Q | 2023-03-31 | 2023-05-09 | 168 | Open |
| FY2022 | 10-K | 2022-12-31 | 2023-03-16 | 483 | Open |
| FY2022 Q3 | 10-Q | 2022-09-30 | 2022-11-03 | 189 | Open |
| FY2022 Q2 | 10-Q | 2022-06-30 | 2022-08-03 | 136 | Open |
| FY2022 Q1 | 10-Q | 2022-03-31 | 2022-05-04 | 127 | Open |
| FY2021 | 10-K | 2021-12-31 | 2022-03-14 | 363 | Open |
| FY2021 Q3 | 10-Q | 2021-09-30 | 2021-11-08 | 117 | Open |
| FY2021 Q2 | 10-Q | 2021-06-30 | 2021-08-09 | 114 | Open |
| FY2021 Q1 | 10-Q | 2021-03-31 | 2021-05-17 | 113 | Open |
| FY2020 | 10-K | 2020-12-31 | 2021-03-29 | 327 | Open |
| FY2020 Q3 | 10-Q | 2020-09-30 | 2020-11-05 | 132 | Open |
Financial data
402 concepts · 6,073 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial397 concepts · 5,953 facts · Dec 2013 to Jun 2023
- Allocated share based compensation expense48 · Dec 2013 to Jun 2023
- Cash and cash equivalents at carrying value48 · Dec 2013 to Jun 2023
- Costs and expenses48 · Dec 2013 to Jun 2023
- Net income loss48 · Dec 2013 to Jun 2023
- Operating income loss48 · Dec 2013 to Jun 2023
- Research and development expense excluding acquired in process cost48 · Dec 2013 to Jun 2023
- Other nonoperating income expense47 · Mar 2014 to Jun 2023
- Increase decrease in accounts payable and accrued liabilities46 · Dec 2013 to Jun 2023
- Share based compensation46 · Dec 2013 to Jun 2023
- Stockholders equity (US GAAP)45 · Dec 2013 to Jun 2023
- Common stock par or stated value per share44 · Dec 2014 to Jun 2023
- Common stock value44 · Dec 2014 to Jun 2023
- Increase decrease in other operating capital net44 · Dec 2013 to Jun 2023
- Revenue44 · Dec 2013 to Jun 2023
- Accounts payable current43 · Dec 2014 to Jun 2023
- Accrued professional fees current43 · Dec 2014 to Jun 2023
- Additional paid in capital common stock43 · Dec 2014 to Jun 2023
- Assets43 · Dec 2014 to Jun 2023
- Assets current43 · Dec 2014 to Jun 2023
- Common stock shares authorized43 · Dec 2014 to Jun 2023
- Common stock shares issued43 · Dec 2014 to Jun 2023
- Common stock shares outstanding43 · Dec 2014 to Jun 2023
- Comprehensive income net of tax43 · Dec 2014 to Jun 2023
- Employee related liabilities current43 · Dec 2014 to Jun 2023
Product1 concept · 83 facts · Mar 2018 to Jun 2023
- Revenue83 · Mar 2018 to Jun 2023
Geography4 concepts · 37 facts · Dec 2015 to Dec 2021
- Operating Lease Expiry Period24 · Dec 2015 to Dec 2021
- Operating Lease Monthly Rent Expenses11 · Dec 2015 to Dec 2020
- Property plant and equipment additions1 · Mar 2017
- Property plant and equipment disposals1 · Mar 2017
Segments
120 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service4 members · 83 facts
- Collaboration and Royalty Revenue [Member]27 · Mar 2018 to Jun 2023
- Product Revenue, Net [Member]22 · Mar 2019 to Jun 2023
- Government Contract Grant Revenue [Member]17 · Mar 2020 to Jun 2023
- Government Contract Service Revenue [Member]17 · Mar 2020 to Jun 2023
Statement geographicalus-gaap:StatementGeographicalAxis3 members · 20 facts
- Boston [Member]10 · Dec 2015 to Mar 2018
- King of Prussia [Member]8 · Dec 2015 to Mar 2018
- King of Prussia and Boston [Member]2 · Mar 2017
Statement geographicalsrt:StatementGeographicalAxis2 members · 17 facts
- Boston [Member]11 · Dec 2018 to Dec 2021
- King of Prussia [Member]6 · Dec 2018 to Dec 2021
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of PARATEK PHARMACEUTICALS, INC. (PRTK) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 20, 2026) and refreshed every few hours.